TAMIFLU 75 mg, hard capsule 10 capsules
Active ingredients: Oseltamivir, Oseltamivir phosphate
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule10 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TAMIFLU 75 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC polyéthylène PVDC aluminium de 10 gélule(s)
- Marketing authorisation holder
- ROCHE REGISTRATION (ALLEMAGNE)
- Reimbursement according to BDPM
- 15 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 Nov 2002
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63601338CIP73599629CIP133400935996299Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| OSÉLTAMIVIR (PHOSPHATE D')gélule | 98,5 mg · une gélule | SA |
| OSÉLTAMIVIRgélule | 75 mg · une gélule | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.